MedTrace Logo

A Multinational Trial to Evaluate the Longterm Safety of the Parachute Implant System

NCT01297296 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2017-06-22

No results posted yet for this study

Summary

The primary objective is to assess the longterm safety of the CardioKinetix Parachute Implant and Delivery System in the partitioning of the left ventricle in patients with heart failure due to ischemic heart disease.

Conditions

Sponsors & Collaborators

  • CardioKinetix, Inc

    lead INDUSTRY

Principal Investigators

  • Simon Redwood, MD · St. Thomas' Hospital

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2014-06-30
Completion
2017-06-30

Countries

  • Belgium
  • Germany
  • Italy
  • Netherlands
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01297296 on ClinicalTrials.gov